Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial

BACKGROUND: Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) reduces hospitalizations among outpatients treated early after symptom onset. It is unknown whether CCP reduces time to symptom resolution among outpatients. METHODS: We evaluated symptom resolution at day 14 by trial arm usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Baksh, Sheriza N, Heath, Sonya L, Fukuta, Yuriko, Shade, David, Meisenberg, Barry, Bloch, Evan M, Tobian, Aaron A R, Spivak, Emily S, Patel, Bela, Gerber, Jonathan, Raval, Jay S, Forthal, Donald, Paxton, James, Mosnaim, Giselle, Anjan, Shweta, Blair, Janis, Cachay, Edward, Currier, Judith, Das, Piyali, Huaman, Moises, Sutcliffe, Catherine, Yarava, Anusha, Casadevall, Arturo, Sullivan, David, Hanley, Daniel, Gebo, Kelly A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226658/
https://www.ncbi.nlm.nih.gov/pubmed/36722044
http://dx.doi.org/10.1093/infdis/jiad023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226658/
https://www.ncbi.nlm.nih.gov/pubmed/36722044
http://dx.doi.org/10.1093/infdis/jiad023

Ejemplares similares